AKT1 and non-small cell lung carcinoma: From these data we conclude, that the expression of activated Akt1 in A549 human NSCLC cells can cause partial resistance towards a defined class of chemotherapeutics, namely DNA reactive agents, but in our system does not alter the sensitivity towards cell cycle (M-phase) specific chemotherapeutics like paclitaxel.